Another study provided the first evidence that butyrate (oral but not intravenous administration) improved energy metabolism via the gut–brain neural circuit in a cholesteryl ester transfer protein (CETP) mouse model (a translational model for diet-induced obesity akin to that in humans). Here, CETP is linked to obesity disorder.